BAYHILL THERAPEUTICS

June 26, 2010
American Diabetes Association 70th Scientific Sessions
Pediatric Diabetes – Clinical Aspects of Beta Cell Function,
RG7426 (BHT-3021) – Phase I Study
Orange County Convention Center, Orlando, Fl
Speaker: Peter Gottlieb, M.D.

June 24, 2010
FOCIS 2010
"Mechanistic Insights from Islet-Specific DNA Vaccines"
Boston, MA. USA
Speaker: Nanette Solvason, Ph.D.

March 16, 2009
Bio-Europe Spring 2009
Panel: “Executing Business Strategies in an Era of Regulatory Transition”
Milano Convention Center, Milan, Italy
Speaker: Mark W. Schwartz, Ph.D., CEO and President Bayhill Therapeutics, Inc.

March 17, 2009
Bio-Europe Spring 2009
Bayhill Therapeutics, Partnering Forum Presentation
Milano Convention Center, Milan, Italy
Speaker: Mark W. Schwartz, Ph.D., CEO and President Bayhill Therapeutics, Inc.

April 20-23, 2009
The 9th Annual World Vaccine Congress
Westfields Marriott Washington Dulles, VA
Panelist: Hideki Garren, MD, PhD

May 11-13, 2009
The Neurotech Industry Investing and Partnering Conference 2009
"NeuroVaccines: The Use of Vaccines in Neurology and Psychiatry"
St. Regis, San Francisco
Speaker: Mark W. Schwartz, Ph.D., CEO and President
Bayhill Therapeutics, Inc.

May 20, 2009
2009 Bio International Convention, Breakout Session: “Renewing the Promise of DNA Vaccines: Strategies to Enhance Delivery, Efficacy and Immunogenicity”
Georgia World Congress Center, Atlanta, GA
Speaker: Hideki Garren, MD, PhD

May 21, 2009
2009 Bio International Convention, JDRF Breakout Session: “The New Frontier of Vaccines for Autoimmunity Diseases- Development of a Novel Tolerance-Inducing Immunotherapeutics”
Georgia World Congress Center, Atlanta, GA
Speaker: Hideki Garren, MD, PhD